» Articles » PMID: 28921418

Coping with Phantom Limb Pain

Overview
Journal Mol Neurobiol
Date 2017 Sep 19
PMID 28921418
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Phantom limb pain is a chronic neuropathic pain that develops in 45-85% of patients who undergo major amputations of the upper and lower extremities and appears predominantly during two time frames following an amputation: the first month and later about 1 year. Although in most patients the frequency and intensity of pain diminish over time, severe pain persists in about 5-10%. It has been proposed that factors in both the peripheral and central nervous systems play major roles in triggering the development and maintenance of pain associated with extremity amputations. Chronic pain is physically and mentally debilitating, affecting an individual's capacity for self-care, but also diminishing an individual's daily capacity for personal and economic independence. In addition, the pain may lead to depression and feelings of hopelessness. A National Center for Biotechnology Information study found that in the USA alone, the annual cost of dealing with neuropathic pain is more than $600 billion, with an estimated 20 million people in the USA suffering from this condition. Although the pain can be reduced by antiepileptic drugs and analgesics, they are frequently ineffective or their side effects preclude their use. The optimal approach for eliminating neuropathic pain and improving individuals' quality of life is the development of novel techniques that permanently prevent the development and maintenance of neuropathic pain, or that eliminate the pain once it has developed. What is still required is understanding when and where an effective novel technique must be applied, such as onto the nerve stump of the transected peripheral axons, dorsal root ganglion neurons, spinal cord, or cortex to induce the desired influences. This review, the second of two in this journal volume, examines the techniques that may be capable of reducing or eliminating chronic neuropathic pain once it has developed. Such an understanding will improve amputees' quality of life by blocking the mechanisms that trigger and/or maintain PLP and chronic neuropathic pain.

Citing Articles

Neuroenhancement by repetitive transcranial magnetic stimulation (rTMS) on DLPFC in healthy adults.

Ebrahimzadeh E, Sadjadi S, Asgarinejad M, Dehghani A, Rajabion L, Soltanian-Zadeh H Cogn Neurodyn. 2025; 19(1):34.

PMID: 39866659 PMC: 11759757. DOI: 10.1007/s11571-024-10195-w.


Cryoneurolysis for phantom limb pain: a systematic review.

Brancaccio H, Goodwin B, DesRochers J, Birnbaum A, Cagatay U, Koutsenko B Pain Manag. 2024; 14(12):673-680.

PMID: 39707720 PMC: 11703452. DOI: 10.1080/17581869.2024.2441650.


Neuropsychiatric drugs and a neurophysiological marker as predictors of health-related quality of life in patients with phantom limb pain.

Costa V, Pacheco-Barrios K, Gianlorenco A, Fregni F Pain Med. 2024; 25(11):679-686.

PMID: 38964349 PMC: 11532630. DOI: 10.1093/pm/pnae053.


Repetitive transcranial magnetic stimulation (rTMS) as a tool for cognitive enhancement in healthy adults: a review study.

Asgarinejad M, Saviz M, Sadjadi S, Saliminia S, Kakaei A, Esmaeili P Med Biol Eng Comput. 2023; 62(3):653-673.

PMID: 38044385 DOI: 10.1007/s11517-023-02968-y.


Interplay Between Innovation and Intersubjectivity: Therapists Perceptions of Phantom Motor Execution Therapy and Its Effect on Phantom Limb Pain.

Pilch M, van Rietschoten T, Ortiz-Catalan M, Lendaro E, Van der Sluis C, Hermansson L J Pain Res. 2023; 16:2747-2761.

PMID: 37577161 PMC: 10422994. DOI: 10.2147/JPR.S412895.


References
1.
Hanley M, Ehde D, Campbell K, Osborn B, Smith D . Self-reported treatments used for lower-limb phantom pain: descriptive findings. Arch Phys Med Rehabil. 2006; 87(2):270-7. DOI: 10.1016/j.apmr.2005.04.025. View

2.
McCallum J, Kwok W, Sapunar D, Fuchs A, Hogan Q . Painful peripheral nerve injury decreases calcium current in axotomized sensory neurons. Anesthesiology. 2006; 105(1):160-8. PMC: 3725035. DOI: 10.1097/00000542-200607000-00026. View

3.
Makin T, Scholz J, Henderson Slater D, Johansen-Berg H, Tracey I . Reassessing cortical reorganization in the primary sensorimotor cortex following arm amputation. Brain. 2015; 138(Pt 8):2140-6. PMC: 4511862. DOI: 10.1093/brain/awv161. View

4.
Kuffler D, Reyes O, Sosa I, Santiago-Figueroa J . Neurological recovery across a 12-cm-long ulnar nerve gap repaired 3.25 years post trauma: case report. Neurosurgery. 2011; 69(6):E1321-6. DOI: 10.1227/NEU.0b013e31822a9fd2. View

5.
Sluka K, Deacon M, Stibal A, Strissel S, Terpstra A . Spinal blockade of opioid receptors prevents the analgesia produced by TENS in arthritic rats. J Pharmacol Exp Ther. 1999; 289(2):840-6. View